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Abstract: MytiLec is an α-D-galactose-binding lectin with a unique primary structure isolated from
the Mediterranean mussel (Mytilus galloprovincialis). The lectin adopts a β-trefoil fold that is also
found in the B-sub-unit of ricin and other ricin-type (R-type) lectins. We are introducing MytiLec(-1)
and its two variants (MytiLec-2 and -3), which both possess an additional pore-forming aerolysin-like
domain, as members of a novel multi-genic “mytilectin family” in bivalve mollusks. Based on the
full length mRNA sequence (911 bps), it was possible to elucidate the coding sequence of MytiLec-1,
which displays an extended open reading frame (ORF) at the 51 end of the sequence, confirmed
both at the mRNA and at the genomic DNA sequence level. While this extension could potentially
produce a polypeptide significantly longer than previously reported, this has not been confirmed
yet at the protein level. MytiLec-1 was revealed to be encoded by a gene consisting of two exons
and a single intron. The first exon comprised the 51UTR and the initial ATG codon and it was
possible to detect a putative promoter region immediately ahead of the transcription start site in the
MytiLec-1 genomic locus. The remaining part of the MytiLec-1 coding sequence (including the three
sub-domains, the 31UTR and the poly-A signal) was included in the second exon. The bacteriostatic
activity of MytiLec-1 was determined by the agglutination of both Gram-positive and Gram-negative
bacteria, which was reversed by the co-presence of α-galactoside. Altogether, these data support the
classification of MytiLec-1 as a member of the novel mytilectin family and suggest that this lectin
may play an important role as a pattern recognition receptor in the innate immunity of mussels.
Keywords: bacteriostatic activity; cDNA; gene; innate immunity; mytilectin family;
Mytilus galloprovincialis; mRNA-sequence; MytiLec-1; R-type lectin
1. Introduction
Revealing the mechanism of the primordial immunity of marine invertebrates holds a great
potential in providing a detailed understanding on their adaptation the marine environment
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based on evolutionary diversification, about the functioning of the marine ecosystem and can also
provide useful information for the improvement of biomonitoring programs. The advent of next
generation nucleotide sequencing technologies permitted to study in great detail the transcriptome
of non-model marine species, including bivalve mollusks, and also allowed to obtain valuable
information about gene-encoded molecules relevant for the functioning of the innate immune system
of these organisms [1–6]. A recent RNA-sequencing approach applied to the Mediterranean mussel
(Mytilus galloprovincialis), a worldwide economically-important marine bivalve species, elucidated the
presence of several lectins (carbohydrate-binding proteins), that act as pattern recognition receptors
(PRRs) [4]. PRRs are evolutionary conserved families of extracellular, membrane-bound, and cytosolic
molecules that play significant roles in the primitive part of immune system through the recognition of
pathogen-associated molecular patterns (PAMPs) [7], and which cover a particularly important role in
invertebrate organisms, which lack an adaptive immune system.
The purification of an α-D-Gal-binding lectin, MytiLec (renamed MytiLec-1 in the present
manuscript), from M. galloprovincialis has been reported in a previous publication [8]. This 17 kDa
polypeptide (with 149 amino acids in its primary structure) contains three tandemly-repeated
50- amino acids sub-domains [9]. The 3-D structure of MytiLec-1 obtained by crystallographic analysis
revealed a β-trefoil folding [10], which is also found in the ricin B-sub-unit type (R-type) lectins,
a widespread lectin family present in bacteria, plants, and animals. Additionally, the 3-D structure
indicated that MytiLec was a non-covalently bound dimer consisting of two polypeptides displaying
an α-GalNAc-binding activity in each sub-domain [11], with six α-galactoside-binding sites present
in a single molecule. Two D-Gal/GalNAc-binding lectins (named CGL and MTL, respectively) have
later been described in two other mussel (suborder Mytiloida) species, Crenomytilus grayanus and
Mytilus trossulus, and they were found to possess antimicrobial activities. The deduced amino acids
sequence from the cDNA of these lectins indicated that MytiLec-1, CGL, and MTL shared high
sequence similarity (with 83%–84% identity) [12,13]. Such a remarkable degree of similarity suggests
that the possibility to introduce a novel structural family of lectins which comprises all the MytiLec-like
sequences found in bivalves. This viewpoint has been strongly supported by a transcriptome analysis
performed in M. galloprovincialis, which revealed the presence of two other sequences similar to
MytiLec-1, named MytiLec-2 and MytiLec-3 in the same species [4]. Unlike MytiLec-1, CGL, and
MTL, MytiLec-2 and -3 contain an additional pore-forming aerolysin [14]-like domain located at
the C-terminus of the polypeptide that possibly creates pores into pathogenic organisms, thereby
contributing to their killing. This aerolysin-like domain, originally found in bacteria, has been recently
shown to display a much broader taxonomic range of distribution, as it was identified in a relatively
large number of animal, plant, and fungal proteins, most of them with a cytotoxic function [15].
On the other hand, MytiLec-1 does not have any additional C-terminal domains and only consists
of a glycan-binding domain. Nevertheless, the possibility that MytiLec-1 could similarly have a role in
the killing and clearance of foreign cells was strongly hinted by the specific induction of apoptosis
observed in human Burkitt’s lymphoma cells through multiple pathways. It was demonstrated that
these tumor cells express Gb3 glycans that contain α-galactose as a target carbohydrate recognized by
this lectin [16]. As a bacteriostatic activity has already been described for CGL and MTL, the evidence
of a similar activity in MytiLec-1 could confirm a common physiological role for other members of this
novel lectin family.
MytiBase is the result of joint international effort to build a database of transcripts expressed
in M. galloprovincialis by using expressed sequence tag (EST) libraries, with a particular focus on
immune-related sequences. The partial cDNA sequence of MytiLec-1 is present in the database since
2009 (MGC00918, resulting from the assembly of 5 EST sequences) [17]. In the present manuscript we
report of the full-length sequence of the cDNA (and deduced polypeptide) of MytiLec-1, providing
useful information to gain novel insights into the characteristic immune-related properties of this
lectin and of the related sequences MytiLec-2 and 3. The information gathered from the analysis
of this sequence can be, to some extent, extended to the other members of the “mytilectin family”,
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helping to better understand how these molecules function as PRRs and take part in the mussel innate
immune response.
To provide highly reliable sequence information, both a cDNA cloning and transcriptome
sequencing (RNA-seq) analysis approach were undertaken. Although MytiLec-1, like galectin-1,
lacks a signal peptide sequence, we showed that it displays a previously unreported extension of
the ORF at the 51 end of the mRNA sequence. The virtually-translated protein sequence contained
a 37 amino acid-long extension at the N-terminus compared to the previously reported sequence of
MytiLec-1 [17], possibly corresponding to a non-classical secretion signal. Additionally, we elucidated
the structure of the MytiLec-1 gene, which consisted of two exons and one intron, and we preliminarily
investigated its expression in mussel tissues, identifying mantle and gills as the preferential sites of
production. Furthermore, we observed that this lectin could exert a bacteriostatic activity similar to
that of CGL and MTL, further supporting a common function for all the members of the mytilectin
family. Altogether, these results support the idea that MytiLec-1 may function as a PRR molecule
involved in the innate immunity of mussels.
2. Results and Discussion
2.1. cDNA Sequence of Mytilec-1 and Virtual Translation of the Polypeptide
The cDNA sequence of MytiLec-1 was identified by Sanger’s dideoxy sequencing method and
further confirmed by the analysis of de novo assembled RNA-sequencing data (Figure 1). The nucleotide
sequence consisted of 911 base pairs (GenBank LC125182.1) [18] and it displayed high homology
with the cDNAs encoding lectins from Mytilus californianus (GenBank KT695159.1) [19], M. trossulus
(GenBank KR019779.1) [20], and Crenomytilus grayanus (GenBank JQ314213.1) [21]. In particular, the
whole nucleotide sequence (450 bps) corresponding to the predicted M. californianus polypeptide
(149 amino acids) was found to be 100% identical between the two species. This fact was somewhat
surprising, as M. galloprovincialis and M. californianus are two genetically and morphologically distinct
species [22]. Such a high degree of similarity at the nucleotide level between these two species could
only be explained by introgression, a phenomenon much more spread than originally thought [23],
or by species misidentification. On the other hand, the coding nucleotide sequence of MytiLec-1
displayed 88% and 89% identity with MTL and CGL, respectively.
Remarkably, the MytiLec-1 cDNA showed the presence of an additional translatable nucleotide
sequence consisting of 111 bps found ahead of the ATG codon corresponding to the amino acidic
residue 1Met in the other mytilectin sequences deposited in GenBank (Figure 1, underlined).
The absence of STOP codons within this region was confirmed by both 51RACE and by
RNA-sequencing. This region possibly encodes a 37 amino acid segment which has no similarity with
other sequences deposited in GenBank, as suggested by the absence of significant BLAST hits. The
open reading frame is preceded by a 51UTR region consisting of 148 nucleotides. The 51UTR of the
M. californianus lectin mRNA (GenBank KT695159.1) [19] deposited sequence was nearly identical, but
much shorter, than that of MytiLec-1, thereby lacking the putative translation start codon observed in
MytiLec-1. Furthermore, a recent transcriptome analysis of M. trossulus (another species pertaining to
the M. edulis species complex and closely related to M. galloprovincialis) showed that this 51 extension is
also present in the full length mRNA encoding the MTL polypeptide [24].
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1 a atg gta tag agg cgt cca acc gca gac 28
29 aga ttg aca agt tat att gca aaa agt att gca cta ttt ctt ctc att ggc tag aca tat 88
89 tca ata aca gac gat tgg aat act agt ttg agc ttg aat taa tcc gct ggt gca cta taa 148
149 ATG ACT GCT GGT AAA CAA AGT TGC TTT AAT AGC ATT ATA TTA TTA TCC ATA GCG ACA TCG 208
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209 TAT TTC AAA ATC GGA CAC AAA ATA TCC GAA CTT GGA AAT CGT ATA GAG AAA ATG ACT ACG 268
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449 CAT CCC CTC GGT GGA AAA GCT GAC CCA CCA AAT GAA ACC AAG TTG GTT CTG CAT CAA GAC 508
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749 tgg cta gct taa tcg tta gtt ttt ttg tat ata taa tgc atg aga agg ttt tga cat atc 808
809 ata cat aga agt ttg tta caa ata aac aac att gat ctg ttg ttg ttc ttt ata tat aat 868
869 aaa taa cgc atc gtt gat tac aaa aaa aaa aaa aaa aaa aaa a 911  
Figure 1. cDNA sequence and deduced amino acid sequence of MytiLec‐1. Bold and italic numbers 
indicate nucleotides and amino acids, respectively. 38Met (yellow background) correspond to the first 
amino  acidic  residue  of  the mature MytiLec‐1 polypeptide. The  alternative N‐terminal  extension 
sequence is underlined. The asterisk indicates the stop codon. 
However, it is noteworthy that the N‐terminal sequence of translated MytiLec‐1 observed in a 
previous  study was  initiated  from  acetylated‐39TTFLIK—[8]  (Figure  1). Therefore,  the  alternative 
N‐terminal extension sequence coding 1MTAGK—here reported, it does not appear to be part of the 
mature  polypeptide. Different  hypotheses  could  explain  this  discrepancy:  (i)  contest‐depending 
leaky scanning [25], which would determine the bypass of the initial ATG codon by the ribosomal 
40S subunits  in  favor of  the  second ATG codon  (encoding  38Met);  (ii) processing by an unknown 
extracellular protease, which would cleave off the 37 amino acid‐long N‐terminal extension, possibly 
corresponding  to  a  non‐canonical  secretion  signal;  (iii)  the  production  of MytiLec‐1  isoforms  of 
different  length (either starting from  1Met or  38Met) by the use of different transcription start sites 
(TSS) under a dispersed promoter model (Section 2.3). The identification of the protein processing 
system  involved  in  the  maturation  of  MytiLec‐1  will  also  be  important  to  understand  the 
physiological  function of  this  lectin and  its orthologous molecules expressed  in other species and 
genera. 
2.2. Comparison of Deduced Primary Structures among M. galloprovincialis Mytilectins 





conformations  (MytiLec‐1  is  the  prototype  having  only  a  glycan‐binding  domain,  whereas 
MytiLec‐2 and ‐3 combine a lectin and a pore‐forming aerolysin‐like domain) confirms the presence 
of a multi‐genic “mytilectin family” in this genus of marine bivalve mollusks. Additionally, most of 
Figure 1. cDNA sequence and deduced amino acid sequence of MytiLec-1. Bold and italic numbers
indicate nucleotides and amino acids, respectively. 38Met (yellow background) correspond to the
first amino acidic residue of the mature MytiLec-1 polypeptide. The alternative N-terminal extension
sequence is underlined. The asterisk indicates the stop codon.
However, it is noteworthy that the N-terminal sequence of t anslated MytiLec-1 observed in
a previous study was initiated fr m acetylated-39TTFLIK—[8] (Figure 1). Therefore, the alternative
N-terminal extension sequence coding 1MTAGK—here reported, it does not appear to be part of
the mature polypeptide. Different hypotheses could explain this discrepancy: (i) contest-depending
leaky scanning [25], which would determine the bypass of the initial ATG codon by the ribosomal
40S subunits in favor of the second ATG codon (encoding 38Met); (ii) processing by an unknown
extracellular protease, which would cleave off the 37 amino acid-long N-terminal extension, possibly
corresponding to a non-canonical secretion signal; (iii) the production of MytiLec-1 isoforms of different
length (either starting from 1Met or 38Met) by the use of different transcription start sites (TSS) under
a dispersed promoter model (Section 2.3). The identification of the protein processing system involved
in the maturation of MytiLec-1 will also be important to understand the physiological function of this
lectin and its orthologous molecules expressed in other species and genera.
2.2. Comparison of Deduced Primary Structures among M. galloprovincialis Mytilectins
The primary structure of MytiLec-1 was determined to be 60% and 63% identical with
corresponding deduced amino acid sequences of the glycan-binding domain of MytiLec-2 (GenBank
KP125931.1) [26] and MytiLec-3 (GenBank KP125932.1) [27], respectively (Figure 2). This result
can provide quite a valuable evidence for what concerns the innate immunity-related function of
these lectins i mussels. The presence of different types of mytilecti s (MytiLec-1, -2, and -3) with
different onformati ns (MytiLec-1 is the p ototype having only a glycan-binding domain, whereas
MytiLec-2 and -3 combine a lectin and a pore-forming aerolysin-like domain) confirms the presence
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of a multi-genic “mytilectin family” in this genus of marine bivalve mollusks. Additionally, most of
the six essential amino acids (Figure 2, asterisks) that are involved in the recognition and binding of
α-N-acetyl D-galactosamine [10] in MytiLec-1 were also conserved in MytiLec-2 and -3, suggesting







Figure  2.  Deduced  amino  acid  sequences  of  the  three members  of  the mytilectin  family  in M. 
galloprovincialis (MytiLec‐1, ‐2, and ‐3). Alternative N‐terminal extension (orange), first sub‐domain 




Furthermore,  the  alternative  N‐terminal  extension  sequence  observed  in  MytiLec‐1  is  not 
present  in MytiLec‐2 nor  in MytiLec‐3  (dashed  lines of MytiLec‐2 and  ‐3  in Figure 2). The reason 
behind  this  difference will  be  studied  by  the  comparison  of  gene  structures  among  prototype 
(MytiLec‐1) and chimera‐type  (MytiLec‐2 and  ‐3) members of  the mytilectin  family. However, as 
previously  noted,  the  longer  N‐terminal  region  of  MytiLec‐1  might  comprise  a  non‐classical 
secretion signal (cleaved off upon the release of the peptide in the extracellular space) [4] or may not 
be translated at all due to context‐depending leaky scanning. Different roles of each family member 
Figure 2. Deduced amino acid sequences of the three members of the mytilectin family in M.
galloprovincialis (MytiLec-1, -2, and -3). Alternative N-terminal extension (orange), first sub-domain
(blue), second sub-domain (green), third sub-domain (pink), and aerolysin-like domain (gray) are
shown here. Asterisks denote amino acids essential to ensure the sugar-binding properties [10].
Bold characters within these essential amino acids indicate amino acids that are conserved compared
to MytiLec-1.
Furthermore, the alte native N-termin l extension sequenc observed MytiLec-1 is not present
in MytiLec-2 nor in MytiLec-3 (dashed lines of MytiLec-2 a d -3 in Figure 2). The reason behind this
differenc will be studi d b the compariso of gen structures among prototype (MytiLec-1) and
chimera-type (MytiLec-2 a d -3) m mbers of the mytilectin family. However, as previously noted,
the longer N-terminal region of MytiLec-1 might comprise a non-classical secretion signal (cleaved
off upon the release of the peptide in the extracellular space) [4] or may not be translated at all due
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to context-depending leaky scanning. Different roles of each family member and their regulation
in response to external stimuli (e.g., bacterial challenges) will be investigated in the near future to
understand the specific function of these lectins as PRR molecules.
2.3. The MytiLec-1 Gene Comprises Two Exons
We investigated the gene structure of MytiLec-1 using the partial genome data available for
M. galloprovincialis. The gene consisted of two exons and one intron, with a total length of about
1.5 Kb (Figure 3). The first exon comprised the 51 untranslated region, the alternative initial ATG
codon (encoding 1Met) and covered the first 23 amino acids of the N-terminal extension of the
virtually-translated polypeptide. The remaining part of the MytiLec-1 coding sequence was included
in the second exon, together with the 31UTR and the poly-adenylation site (Figure 3). The two exons
were separated by a 676 nucleotides long phase 0 intron. The analysis of the RNA-seq coverage towards
the 51 end of the gene revealed a remarkable feature, as it appears that the coverage drop, which is
expected from RNA-seq libraries obtained by mRNA fragmentation protocols, was particularly abrupt,
and occurred in a region very close to the nucleotide positions encoding 1Met. This could indicate
the presence of two or more distinct transcription start sites (TSS) which could be alternatively used
under a dispersed promoter model. The most frequently used TSS, based on the coverage analysis,
would originate a shorter version of MytiLec-1, missing the initial ATG codon and, therefore, devoid
of the initial 37 amino acid residues, resulting in a translated polypeptide fully alignable to the M.
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ATG  codon and,  therefore, devoid of  the  initial 37 amino acid  residues,  resulting  in a  translated 
polypeptide fully alignable to the M. californianus lectin deposited in GenBank. 
 
Figure  3. Gene  structure  of MytiLec‐1.  The gene and  its promoter are  indicated as blue and  red 
arrows,  respectively. Two  exons of  the  lectin  are  indicated  as  a  broken green  arrow. The  coding 




a  second  longer  version  of  the MytiLec‐1  transcript  is  produced,  actually  corresponding  to  the 
sequence  reported  in  Figure  1  and  consistent with  the  cloning  results  of  5′RACE. Although  the 
precise position of the transcription start sites is dubious, we could detect RNA‐seq reads mapped 
up  to  position  −148  (compared  to  the  initial  ATG  codon),  partially  overlapping  the  putative 
promoter region, predicted to cover the region between −143 and −192 in the MytiLec‐1 locus. 
The  RNA‐seq  mapping  graphs  obtained  from  different  tissues  collected  from  adult 
unchallenged mussels (Figure 4) indicated that MytiLec‐1 was highly expressed in gills in addition 
to the mantle (the tissue where MytiLec‐1 was originally purified [8]). Within the mantle, MytiLec‐1 
appeared  to  be  expressed  in  increasing  amounts moving  from  the  anterior  towards  the  posterior 
region. The observed expression levels were comparatively much lower in the digestive gland and in 
the posterior adductor muscle, whereas the transcript was barely detectable in hemocytes (RPKM < 1). 
These results point out a remarkably high  level of expression of  the MytiLec‐1 mRNA  in specific 
tissues (gills and mantle) which are constantly exposed to the outer environment, suggesting that 
Figure 3. Gene structure of MytiLec-1. The gene and its promoter are indicated as blue and red arrows,
respectively. Two exons of the lectin are indicated as a broken green arrow. The coding sequence,
including the N-terminal alternative extension, is indicated by a yellow arrow, and the position 38Met
is indicated by a black arrow. The RNA-seq mapping graphs obtained from digestive gland and gills
clearly mark the location of exon/intron junctions.
However, despite the sharp decrease in 51 sequencing coverage, a number of reads indicate that
a second longer version of the MytiLec-1 transcript is produced, actually corresponding to the sequence
reported in Figure 1 and consistent with the cloning results of 51RACE. Although the precise position
of the transcription start sites is dubious, we could detect RNA-seq reads mapped up to position ´148
(co pared to the initial ATG codon), partially overlapping the putative promoter region, predicted to
cover the region between ´143 and ´192 in the MytiLec-1 locus.
The RNA-seq mapping graphs obtained from different tissues collected from adult unchallenged
mussels (Figure 4) indicated that MytiLec-1 was highly expressed in gills in addition to the mantle
(the tissue where MytiLec-1 was originally purified [8]). Within the mantle, MytiLec-1 appeared to be
expressed in increasing amounts moving from the anterior towards the posterior region. The observed
expression levels were comparatively much lower in the digestive gland and in the posterior adductor
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muscle, whereas the transcript was barely detectable in hemocytes (RPKM < 1). These results point
out a remarkably high level of expression of the MytiLec-1 mRNA in specific tissues (gills and mantle)
which are constantly exposed to the outer environment, suggesting that this lectin could be involved
in the recognition of glycans exposed on the surface of parasitic and symbiotic microorganisms.
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Figure 4. Gene expression of MytiLec-1 in different adult mussel tissues, calculated based on
RNA-seq data. Expression levels are given as RPKM (read per kilobase per million mapped reads).
HEM: hemocytes; DG: digestive gland; GIL: gills; PAM: posterior adductor muscle; AMA: anterior
muscle; MMA: mid mantle; and PMA: posterior mantle.
2.4. Agglutination of Bacteria by MytiLec-1 Signifies Its Bacteriostatic Activity
MytiLec-1 triggered a strong agglutination of bacteria depending on the strain tested (Figure 4)
and suppressed their growth significantly (Table 1). Figure 5 depicts a representative view of the
agglutination of Escherichia coli by the lectin. The agglutination was specifically inhibited by the
co-presence of α-galactoside (Figure 5C) but not by β-galactoside (Figure 5D). Similar results were also
observed in other different bacteria (data not shown). In Gram-negative and Gram-positive bacteria,
the main target glycoconjugates for several lectins are lipopolysaccharide and the lipoteichoic acid,
respectively. These molecules can be considered as PAMPs [28], as they are among the most common
targets of PRRs. Both lipopolysaccharide and lipoteichoic acid were reported to contain α-galactose or
its derivatives [29,30]. Though the mechanism of bacterial agglutination by MytiLec-1 is still unclear,
it is likely that this phenomenon is mediated by the recognition of the aforementioned PAMPs by
members of the mytilectin family acting as PRRs.
The bacteriostatic activity of MytiLec-1 is summarized in Table 1. MytiLec-1 (20 µg/mL)
significantly reduced the growth of a number of bacteria, similarly to what has been previously
described for CGL [12]. Based on the data collected so far, it appears that mytilectins can function
either directly as bacterial growth inhibitors or, after agglutination, as modulators of the immune
response, by triggering the action of other immune cells and molecules in mussels.
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arsenal,  in  addition  to  C‐type,  Con A‐type  (including  galectin),  F‐type,  I‐type,  SUEL/RBL‐type, 
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The  carbohydrate‐binding  profile  of  MytiLec‐1  suggested  that  this  molecule  can  recognize 
α‐galactose/galactoside,  including  N‐acetyl  α‐D‐galactosamine,  like  previously  reported  for  CGL 
Figure 5. Agglutination of E. coli by MytiLec-1. MytiLec-1 (20 µg/mL in (A), (C), and (D)) was applied
to the bacteria with 50 mM of melibiose (Galα1-6Glc) and lactose (Galβ1-4Glc), shown in (C) and (D),
respectively. (B) (PBS) is the negative control without lectin. The black bar indicates a scale of 25 µm.
Table 1. Bacteriostatic activity of MytiLec-1 a.
Bacteria Growth Suppressive Activity (%) Agglutination b
Gram-positive
Bacillus subtilis 74 ˘ 8 ++
Staphylococcus aureus 61 ˘ 3 +
Gram-negative
Escherichia coli 58 ˘ 5 ++
Vibrio parahaemolyticus 67 ˘ 1 ++
a Concentration of MytiLec-1 is 20 µg/mL; b ++ and + mean strong and good, respectively.
Although the mytilectin family displays unique structural features, as the primary structure
of each lectin domain is quite unique, their 3-D structure converges to that of a plant ricin toxin
B-subunit (R-type) lectin obtained from castor bean [31]. Further comparative bioinformatics studies of
transcriptome and genome data will clarify whether the mytilectin gene family is also found in other
mollusks and related phyla or it is taxonomically-restricted to mussels. Among invertebrates, pierisin
in the cabbage butterfly (Pieris rapae) [32] and CEL-III in sea cucumber (Cucumaria echinata) [33] are
well known cases of peptides bearing a structural organization similar to that of mytilectins. These two
proteins have additional ADP-ribosyltransferase and pore-forming domains connected with an R-type
lectin domain and they are able to kill HeLa cells and to trigger the hemolysis of erythrocytes mediated
by Gal/GalNAc saccharides. This may suggest that R-type lectins with a PRR function are relatively
widespread in invertebrates.
It has been largely documented that the injection of pathogenic microorganisms in Mytilus spp.
determines the up-regulation of several transcripts encoding lectins, providing an indication that
these molecules can act as PRRs in sessile marine bivalves [1]. In previous studies, a survey
of lectin and lectin-like transcripts in M. galloprovincialis revealed that R-type lectins are also
part of this lectin arsenal, in addition to C-type, Con A-type (including galectin), F-type, I-type,
SUEL/RBL-type, P-type, and L-type lectins [3]. Many studies support the idea that invertebrate
lectins can function as extracellular PRRs, mirroring the function of membrane-bound PRRs, such as
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Toll-like receptors [6]. The carbohydrate-binding profile of MytiLec-1 suggested that this molecule can
recognize α-galactose/galactoside, including N-acetyl α-D-galactosamine, like previously reported for
CGL [12,34]. The α-galactoside-binding specificity of this lectin makes it a peculiar mussel PRR, as this
property has not been described in the other lectins studied so far in this organism.
The bacteriostatic properties of MytiLec-1, which have been previously reported for other
mytilectins (CGL [12] and MTL [13]) were confirmed in this study. Therefore, it seems likely that
MytiLec-1 acts as a PRR molecule in a similar fashion to other members of the mytilectin family [4].
The specificity of action and functional overlap between MytiLec-1, -2, and -3 will be investigated in
the near future through dedicated studies. One possibility would be that MytiLec-1 has a primary role
in recognition and opsonization, whereas MytiLec-2 and -3 are devoted to directly kill bacteria with
their aerolysin-like domain. It will be possible to link both the direct (as antibacterial initiator) and
indirect (opsonizing activity) effects of MytiLec-1 to its bacteriostatic activity only once the network of
molecules interacting with this lectin will be identified in mussels.
The activation of mitogen-activated protein kinases (MAPKs) molecules and the expression
of tumor necrotic factor (TNF)-α and NF-κB have already been reported in mussels in response to
pathogen challenges [3,35]. Although the specific mechanism of action of MytiLec-1 as a PRR is not yet
known, there is evidence that this lectin can activate signal transduction molecules, such as classical
MAPKs (MAPK/extracellular signal-regulated kinase (MEK) and extracellular signal-regulated kinase
(ERK)), stress-activated MAPK (p38 kinase and c-Jun N-terminal kinase (JNK)) and caspase-3/9 with
the expression of p21 and tumor necrotic factor (TNF)-α in human Burkitt’s lymphoma cells by
the interaction with the target α-galactoside glycan Gb3 [16]. This suggests that MytiLec-1 could
potentially activate these intracellular signal transduction pathways in mussels in response to other
target glycans. JNK and p38, which were activated by the administration of MytiLec-1 in lymphoma
cells, are major players also in the innate immune response of mussel, as they are activated in the
hemocytes of M. galloprovincialis upon infection with pathogenic microorganisms, including Vibrio
bacteria, and by high-temperature exposure [36,37]. Galactose residues could serve as target glycans,
as they are present in the lipopolysaccharide of various Gram-negative bacteria such as Vibrio spp.
and Escherichia coli [38,39]. Additionally, during the purification process of MytiLec-1, mussel tissues
were homogenized with a buffer containing the haptenic sugar D-galactose. The addition of this sugar
effectively increased the yield of the lectin compared to a purification performed with a sugar-free
homogenizing buffer, indicating that a fraction of the MytiLec-1 peptide might have been bound to the
tissue expressing target glycans. Overall, the integration of the genetic and physiological information,
together with these functional evidences, suggests that the mytilectin family may play a crucial role in
the immune system of bivalves.
3. Experimental Design
3.1. cDNA Cloning and Sequencing of MytiLec-1
Total RNA was isolated from the mantle and gill of M. galloprovincialis (collected in the Tokyo
bay, Yokohama, Japan) using TRI reagent® (Molecular Research Center, Cincinnati, OH, USA) and
the Direct-zol RNA Mini Prep Kit (Zymo Research Corporation, Irvin, CA, USA), following the
manufacturer’s instructions. First strand cDNAs for 31 and 51 rapid amplification of cDNA end (RACE)
were synthesized by SuperScript II reverse transcriptase (Thermo Fisher SCIENTIFIC, Waltham, MA,
USA) attached to the 31 and 51 RACE system (Thermo Fisher) from total RNA. The first polymerase
chain reaction (PCR) was performed using GSPF1 (51-260ATGACTACGTTCTTATCAAA279-31 coding
38MTTFLIK44), an abridged universal amplification primer (AUAP), and RTase as a template. The
nested PCR was performed with GSPF2 (51-280AGTGGAAAGTTTCTACCA297-31 coding 47SGKFLHP53)
as a forward primer and with AUAP as a reverse primer. cDNA was synthesized starting from total
RNA and was subjected to 35 cycles of PCR amplification (95 ˝C for 30s, 42 ˝C for 30 s and 72 ˝C for
1 min) in a C1000™ thermal cycler apparatus (Bio-Rad, Hercules, CA, USA). The final elongation step
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was carried out at 72 ˝C for 10 min. The 31 RACE PCR product was subcloned into a pGEM-T easy
vector (Promega, Madison, WI, USA) and the sequence was determined using a BigDye Terminator
v3.1 cycle sequencing kit (Applied Biosystems, Weiterstadt, DE, USA) and an ABI 3130 genetic
analyzer (Applied Biosystems Inc., Foster City, CA, USA). The first strand cDNA for 51 RACE was
synthesized from total RNA with RTase using the sequence-specific primer GSPR1. To create the 51
RACE abridged anchor prime (Thermo Fisher) binding site, the tailing reaction was performed with
terminal deoxynucleotidyl transferase (Thermo Fisher) and dCTP as a substrate. The first PCR to
amplify the 51 RACE PCR product was performed with GSPR1 and AUAP using the dC-tail cDNA
as a template. The nested PCR was performed with GSPR2 and AUAP with the same conditions
mentioned above. The nucleotide sequence obtained by 31 and 51 RACE covering the coding region was
identified as the full-length cDNA of MytiLec-1. The result was confirmed by RT-PCR amplification
using primers GSPF3 (51-139GCACTATAAATGACTGCTGGT159-31) and AUAP with a PrimeSTAR Max
DNA polymerase (TaKaRa Bio Inc., Ohtsu, Japan). The amplified DNA was cloned and sequenced as
described above.
3.2. Transcriptome Analysis of Full Length of MytiLec-1 mRNA
We used the cDNA sequence of MytiLec-1 obtained as described above to screen the
de novo-assembled transcriptome data of M. galloprovincialis obtained from multiple sources, including:
(i) the digestive gland from a mussel population from the Gulf of Trieste [40]; (ii) gills from a mussel
population from the Goro lagoon (Northern Adriatic Sea, Italy); (iii) mixed tissues from mussel
populations from Sete (Mediterranean Sea, France), Gibraltar (Mediterranean Sea, Spain) and Roscoff
(France, English channel) [41]; (iv) gills, posterior adductor muscle, hemocytes, and mantles from
a mussel population from Vigo (Atlantic Sea, Spain) [42]; and (v) anterior, mid and posterior mantles
from a mussel population from Ria Formosa (Atlantic Sea, Portugal) [43]. These RNA-seq datasets
were imported in the CLC Genomics Workbench 8 environment (Qiagen, Hilden, Germany), trimmed
based on quality, and de novo assembled as described in Gerdol et al. 2014 [40].
The assembled transcript corresponding to the putative MytiLec-1 sequence identified by PCR as
described in Section 3.1 was detected by BLASTn. The correct assembly of the MytiLec-1 transcript
consensus was checked by back-mapping RNA-seq reads to the sequence and by a manual assessment
of a uniform and homogenous mapping along the entire coding sequence. The expression level of
MytiLec-1 in different tissues was calculated as RPKM (read per kilo-base per million mapped reads)
with the CLC Genomics Workbench RNA-seq mapping tool (CLC Bio, Aarhus, Denmark) setting the
length and similarity fraction parameters to 0.75 and 0.98, respectively, and match/mismatch/deletion
penalties to 3/3/3. The RNA-seq datasets considered for this analysis were digestive gland [40], gills,
hemocytes, posterior adductor muscle [41], anterior, mid and posterior mantle [43].
3.3. Gene Structure Analysis of MytiLec-1
The raw genomic DNA sequencing reads of M. galloprovincialis derived from the bioproject
PRJNA262617 were downloaded from the NCBI SRA database. Reads were assembled with the de novo
assembly tool of CLC Genomics Workbench 8 and the contig comprising the MytiLec-1 gene was
identified by BLASTn using the transcript sequence as a query. The correctness of the assembled
genomic contig was evaluated by inspecting paired-end reads coverage and the location of the two
exons and of the intron was determined by aligning the MytiLec-1 transcript to the genomic contig with
MUSCLE [44]. The correct position of donor and acceptor splice sites was refined with by NNSPLICE
v. 0.9 [45]. The presence of a putative promoter region was investigated in the region near the putative
transcription start site by NNPP v. 2.2 [46].
3.4. Purification of MytiLec-1
Mantles and gills of M. galloprovincialis were homogenized in 10 volumes (w/v) of 150 mM NaCl
containing 10 mM Tris-HCl, pH 7.5 (TBS). The supernatant (Sup 1) was collected by centrifugation at
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27,500ˆ g for 1 h at 4 ˝C. The precipitate was homogenized in 10 volumes (w/v) of 100 mM D-galactose
containing TBS, and the supernatant (Sup 2) was collected as described above. Sup 2 was dialyzed
extensively against TBS. Sup 1 and Sup 2 were both applied to a melibiosyl-agarose column (5.0 mL),
and the column was washed with TBS until the absorbance of the effluent at 280 nm reached the
baseline level. The lectin was eluted with TBS containing 100 mM melibiose [8].
3.5. Bacteriostatic Assay of MytiLec-1
The bacteriostatic assay was performed following the protocols by Naganuma et al. and
Kovalchuk et al. [11,47]. Gram-positive bacteria (Bacillus subtilis and Staphylococcus aureus) and
Gram-negative bacteria (Escherichia coli and Vibrio parahaemolyticus) were grown overnight in LB Broth
(Lennox) (Sigma-Aldrich Co. Ltd., St. Louis, MO, USA) under standard conditions. After harvesting,
bacteria were washed with PBS and 50 µL of the bacterial suspension (with a turbidity of 0.7 at
600 nm) in PBS (phosphate buffer saline) was used in a quantitative assay by mixing with a serial
dilution of MytiLec-1. The bacterial agglutination was monitored by a light microscope. The washed
bacterial suspension was adjusted to an absorbance of about 1.0 at 600 nm. MytiLec-1 was mixed with
the bacteria at final concentrations of 10, 100, and 200 µg/mL in a flat-type 96-well microtiter plate
and grown at 37 ˝C. The absorbance at 600 nm was monitored every 4 h. The value of the growth
suppressive activity was calculated with the following equation:
Growth suppressive activity p%q “ p1´OD600experiment{OD600controlqˆ 100%
OD600experiment and OD600control are the density of a bacterial suspension grown in the presence of
MytiLec-1 measured at OD600 and density of a control bacteria suspension grown in the absence of
MytiLec-1 determined at OD600, respectively.
4. Conclusions
We defined, for the first time, the presence of a novel structural family termed “mytilectin” in
the mussel M. galloprovincialis. The members of this lectin family (MytiLec-1, -2, and -3) have quite
specific primary structures. They display two types of protein conformations: MytiLec-1 only consists
of a glycan-binding domain, whereas MytiLec-2 and -3 possess both a glycan-binding domain and
a pore-forming aerolysin-like domain. We characterized the MytiLec-1 sequence both at the cDNA
and at the genomic DNA level, evidencing that the mRNA is produced by a gene composed by two
exons and one intron and that this gene is mainly expressed in the mantle and gill tissues. Although
full length cDNA of MytiLec-1 does not encode a classical signal sequence, the virtually-translated
ORF indicates the possible presence of an alternative N-terminal extension sequence of 37 amino acids
which could provide an alternative non-classical secretion signal. However, in absence of experimental
data concerning the use of the first ATG codon as a translation start site, the production of this longer
variant of the polypeptide remains hypothetical. The functional overlap and specificity of action of the
three mussel mytilectins remain issues to be investigated in the near future.
Lastly, we demonstrated the bacteriostatic activity of MytiLec-1. Altogether these results suggest
that MytiLec-1 can function as a pattern recognition receptor molecule in the mussel’s innate immunity.
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